1. Home
  2. TSAT vs RZLT Comparison

TSAT vs RZLT Comparison

Compare TSAT & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSAT
  • RZLT
  • Stock Information
  • Founded
  • TSAT 1969
  • RZLT 2010
  • Country
  • TSAT Canada
  • RZLT United States
  • Employees
  • TSAT N/A
  • RZLT N/A
  • Industry
  • TSAT Metal Fabrications
  • RZLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TSAT Industrials
  • RZLT Health Care
  • Exchange
  • TSAT Nasdaq
  • RZLT Nasdaq
  • Market Cap
  • TSAT N/A
  • RZLT 226.4M
  • IPO Year
  • TSAT 1996
  • RZLT N/A
  • Fundamental
  • Price
  • TSAT $20.89
  • RZLT $3.05
  • Analyst Decision
  • TSAT Hold
  • RZLT Strong Buy
  • Analyst Count
  • TSAT 1
  • RZLT 8
  • Target Price
  • TSAT $9.00
  • RZLT $12.00
  • AVG Volume (30 Days)
  • TSAT 103.5K
  • RZLT 482.0K
  • Earning Date
  • TSAT 05-09-2025
  • RZLT 05-14-2025
  • Dividend Yield
  • TSAT N/A
  • RZLT N/A
  • EPS Growth
  • TSAT N/A
  • RZLT N/A
  • EPS
  • TSAT 2.55
  • RZLT N/A
  • Revenue
  • TSAT $450,756,875.00
  • RZLT N/A
  • Revenue This Year
  • TSAT N/A
  • RZLT N/A
  • Revenue Next Year
  • TSAT N/A
  • RZLT N/A
  • P/E Ratio
  • TSAT $9.01
  • RZLT N/A
  • Revenue Growth
  • TSAT N/A
  • RZLT N/A
  • 52 Week Low
  • TSAT $6.93
  • RZLT $1.76
  • 52 Week High
  • TSAT $25.38
  • RZLT $6.19
  • Technical
  • Relative Strength Index (RSI)
  • TSAT 52.65
  • RZLT 24.55
  • Support Level
  • TSAT $20.60
  • RZLT $3.25
  • Resistance Level
  • TSAT $25.38
  • RZLT $3.81
  • Average True Range (ATR)
  • TSAT 2.12
  • RZLT 0.22
  • MACD
  • TSAT 0.19
  • RZLT -0.05
  • Stochastic Oscillator
  • TSAT 54.09
  • RZLT 4.35

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

Share on Social Networks: